Navigation Links
Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
Date:2/1/2010

83245032';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.resverlogix.com">www.resverlogix.com.

This news release may contain certain forward-looking statements as defined under applicable Canadian securities legislation, including our vision to be a leader in the research, development and commercialization of novel therapeutics that reduce the risk of cardiovascular disease including atherosclerosis, diabetes, Alzheimer's disease, Peripheral Artery Disease and other vascular diseases. These forward-looking statements contained herein that are not based on historical fact, including without limitation statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Our actual results, events or developments could be materially different from those expressed or implied by these forward-looking statements. We can give no assurance that any of the events or expectations will occur or be realized. By their nature, forward-looking statements are subject to numerous known and unknown risks and uncertainties including but not limited to those associated with the success of research and development programs, clinical trial programs including possible delays in patient recruitment, the regulatory approval process, competition, securing and maintaining corporate alliances, market acceptance of the Company's products, the availability of government and insurance reimbursements for the Company's products, the strength of intellectual property, financing capability, the potential dilutive effects of any financing, reliance on subcontractors and key personnel and additional risk factors discussed in other documents we file from time to time with securities authorities, which are available through SEDAR at

SOURCE Resverlogix Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
2. Insulet Appoints Bill Arthur as Vice President of Business Development
3. Ikaria Founding Scientist Named 2007 MacArthur Fellow
4. Basic Scientist Mark Roth Wins MacArthur Fellowship
5. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
6. Inspiring New Online Destination From Bayer Diabetes Care
7. Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U.S.
8. Bayer CropScience Announces Investment of $25 Million for Institute Site
9. Bayers CONTOUR and Bayers BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology
10. DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements
11. Neptune Products to be commercialized by BAYER HealthCare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... N.J. , April 30, 2015  Roka Bioscience, ... focused on providing advanced testing solutions for the detection ... results for the first quarter of 2015 on May ... Roka Bioscience will also host a conference ... 2015 to discuss its first quarter financial results. During ...
(Date:4/30/2015)... 2015 Nitto Avecia, a leading ... increased capacity and production capability to serve biotechnology ... and service fulfillment continues to drive Nitto Avecia ... throughput capacities. , In Fall 2014, ... process equipment at its Milford, MA facility, which ...
(Date:4/30/2015)...  The Paul G. Allen Family Foundation announced today ... six groups of researchers with projects at the frontier ... growing mature human brain cells in the laboratory. The ... over three years.  "This new cohort ... significant because the field of neuronal maturation is at ...
(Date:4/30/2015)... April 30, 2015 WuXi PharmaTech (Cayman) Inc. ... leading global contract R&D services provider, today announced that ... proposal letter, dated April 29, 2015, from a consortium ... (the "Chairman"), founder, chairman and chief executive officer of ... that proposes a transaction (the "Transaction") involving the acquisition ...
Breaking Biology Technology:Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 3The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 5WuXi PharmaTech Announces Receipt of Proposal 2WuXi PharmaTech Announces Receipt of Proposal 3WuXi PharmaTech Announces Receipt of Proposal 4WuXi PharmaTech Announces Receipt of Proposal 5WuXi PharmaTech Announces Receipt of Proposal 6
... Annual Observance To Draw Attention To ,The Sneak Thief ... an effort to combat one of the,main causes of ... World Glaucoma Patient Organization have announced the first annual,World ... The day will be marked,by awareness and educational events ...
... and CLAREMONT, Calif., Jan. 30 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech ... the volume of bio-enhanced feed products sold during ... quarter of 2007 and increased,25% over the same ... Feed Co., Ltd. ("Kiwa Tianjin") is a joint-venture ...
... Tengion Inc., a clinical,stage regenerative medicine company focused ... that Steven Nichtberger, M.D.,President and Chief Executive Officer, ... Biotechnology and Medical Device Conference on,Tuesday, February 5, ... be held at,the Grand Hyatt Hotel in New ...
Cached Biology Technology:World Glaucoma Day Set for March 6th 2Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007 2
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2
... risks posed by pharmaceuticals are not enough to protect ... of Gothenburg (Sweden) who is calling for better environmental ... the combined effects of different drugs to reflect the ... Brosch from the Department of Plant and Environmental Sciences ...
... of scientists from Singapore led by the Genome Institute ... Cell Biology (IMCB), two biomedical research institutes of ... discovered the most important genes in human embryonic stem ... stem cells work. Their research, published in top scientific ...
... National Laboratory researcher Bette Korber is part of an ... the first human trial of a mosaic HIV vaccine ... the virus that causes AIDS by attempting to address ... design: the virus,s extensive genetic diversity. The team ...
Cached Biology News:Environmental risk assessment of pharmaceuticals inadequate 2Singapore scientists first to perform genome-wide study of human stem cells 2Consortium to design human trials of mosaic HIV vaccine 2
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Anti-HumanLactoferrin...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details....
Biology Products: